| Literature DB >> 21596405 |
B Wolfesberger1, Z Tonar, A Fuchs-Baumgartinger, I Walter, M Skalicky, K Witter, J G Thalhammer, M Pagitz, M Kleiter.
Abstract
Angiogenesis, which is essential for malignancies to progress, depends on various signalling proteins including vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptors 1 and 2 (VEGFR-1 and VEGFR-2). Microvessel density (MVD) is frequently used to evaluate angiogenesis. This study assessed the relationship between expression of VEGF, VEGFR-1 and VEGFR-2, MVD and the survival time in dogs with lymphoma. VEGF, VEGFR-1 and VEGFR-2 expression was evaluated immunohistochemically and microvessel profiles were counted in 34 lymphoma samples. Seventy-nine percent of the samples showed high VEGF expression and 62% were highly positive for VEGFR-1; VEGFR-2 immunoreactivity was mostly negative. Dogs treated with chemotherapy had a median survival time of 266days, but no significant relationships were found between overall survival time, MVD and expression of VEGF, VEGFR-1 or VEGFR-2. In this study, VEGF its receptors and the MVD were no prognostic factors in dogs with lymphoma.Entities:
Mesh：
Substances：
Year: 2011 PMID： 21596405 DOI： 10.1016/j.rvsc.2011.04.018
Source DB: PubMed Journal: Res Vet Sci ISSN： 0034-5288 Impact factor: 2.534